A detailed history of Headlands Technologies LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 19 shares of DNA stock, worth $152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 27,927 99.93%
Holding current value
$152
Previous $32,000 100.0%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$0.28 - $1.16 $7,814 - $32,373
-27,908 Reduced 99.93%
19 $0
Q1 2024

May 07, 2024

SELL
$1.06 - $1.67 $109,792 - $172,975
-103,578 Reduced 78.76%
27,927 $32,000
Q4 2023

Feb 02, 2024

BUY
$1.26 - $1.79 $128,829 - $183,020
102,246 Added 349.45%
131,505 $222,000
Q3 2023

Nov 09, 2023

BUY
$1.61 - $2.54 $47,106 - $74,317
29,259 New
29,259 $52,000
Q1 2023

May 01, 2023

BUY
$1.2 - $2.19 $2,175 - $3,970
1,813 New
1,813 $2,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.3B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.